The present invention relates to compounds of formula (I)
wherein R
1
, R
2
, R
3
, R
5
, W, X, X
1
, Y, Y
1
, Z and Z
1
are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds inhibit PDE10A and can be used in the treatment of CNS disorders such as schizophrenia, Alzheimer's disease, and Parkinson's disease.
The present invention relates to compounds of formula (I)
wherein R1, R2, R3, R5, W, X, X1, Y, Y1, Z and Z1 are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds inhibit PDE10A and can be used as medicaments.